𝔖 Bobbio Scriptorium

✦ LIBER ✦

TCT-36 One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials.

✍ Scribed by Muramatsu, Takashi; Onuma, Yoshinobu; Van Geuns, Robert J.; Chevalier, Bernard; Patel, Tejas M.; Seth, Ashok; Diletti, Roberto; Garcia-Garcia, Hector M.; Dorange, Cécile; Veldhof, Susan; Cheong, Wai-Fung; Whitbourn, Robert J.; Bartorelli, Antonio L.; Abizaid, Alexandre; Serruys, Patrick W.

Book ID: 122175961
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 109 KB
Volume: 62
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2013.08.766

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-245: ABSORB Cohort B Trial: Two Year

TCT-245: ABSORB Cohort B Trial: Two Year Clinical and Angiographic Results of the ABSORB Bioresorbable Everolimus Eluting Vascular Scaffold

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB

TCT-245 Diabetic patients treated with B

TCT-245 Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

✍ Iqbal, Javaid; Onuma, Yoshinobu; Van Geuns, Robert J.; Chevalier, Bernard; Muram 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

TCT-35 Evaluation of the Absorb Everolim

TCT-35 Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3 Year Clinical Results of the ABSORB Cohort B1 Trial

✍ Peter Smits 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

EVALUATION OF THE ABSORB EVEROLIMUS ELUT

EVALUATION OF THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD (ABSORB BVS) IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 2 YEAR CLINICAL RESULTS OF ABSORB COHORT B TRIAL

✍ Dariusz Dudek 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 104 KB

THE ABSORB TRIAL: EVALUATION OF THE ABSO

THE ABSORB TRIAL: EVALUATION OF THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 4 YEAR CLINICAL RESULTS OF COHORT B

✍ Christiansen, Evald Hoej 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 181 KB

TCT-592 Incidence, imaging and clinical

TCT-592 Incidence, imaging and clinical outcomes of acute scaffold disruption and late structural discontinuity after implantation of the Absorb everolimus-eluting fully bioresorbable vascular scaffold: Optical coherence tomography assessment in the ABSORB Cohort B trial

✍ Onuma, Yoshinobu; Serruys, Patrick W.; Muramatsu, Takashi; Nakatani, Shimpei; Va 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 299 KB